VitaSpring Biomedical Co (VitaSpring Biomedical Co) EV-to-Revenue : 663.71 (As of May. 12, 2024)

VitaSpring Biomedical Co EV-to-Revenue Chart

VitaSpring Biomedical Co Quarterly Data
	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22
EV-to-Revenue	Get a 7-Day Free Trial															1,349.64	515.17	471.63	658.03	616.01

Competitive Comparison of VitaSpring Biomedical Co's EV-to-Revenue

For the Biotechnology subindustry, VitaSpring Biomedical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VitaSpring Biomedical Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VitaSpring Biomedical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where VitaSpring Biomedical Co's EV-to-Revenue falls into.

VitaSpring Biomedical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

VitaSpring Biomedical Co's EV-to-Revenue for today is calculated as:

VitaSpring Biomedical Co's current Enterprise Value is $3,304.63 Mil.
VitaSpring Biomedical Co's Revenue for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VitaSpring Biomedical Co  (OTCPK:VSBC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

VitaSpring Biomedical Co's PS Ratiofor today is calculated as:

VitaSpring Biomedical Co's share price for today is $16.00.
VitaSpring Biomedical Co's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VitaSpring Biomedical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of VitaSpring Biomedical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

VitaSpring Biomedical Co (VitaSpring Biomedical Co) Business Description